Statistics from Altmetric.com
The paper published by Gold and colleagues,1 illustrates the increasing potential of psychoneuroimmunology in elucidating some of the more enigmatic problems in neuropsychiatry (in press).
The relationship between major depressive disorder (MDD) and multiple sclerosis (MS) is recognised as both close and illustrative. The high prevalence of MDD is predictive of not only poor quality of life but also impaired disease adaptation. Treatment of MDD in this context is also important as there is growing evidence that such treatment might have a positive impact on MS relevant immune markers, such as proinflammatory cytokines. Conversely, immunotherapies for MS show some positive impact on depressive symptoms.
MS is a unique clinical scenario wherein proinflammatory cytokines are released into the CNS by …